https://www.selleckchem.com/
05). OCT anterior chamber cell counts were significantly reduced in the first phase of the study in all treatment groups (P less then 0.001). OCT anterior chamber cell counts and histopathology scores were significantly reduced in the second phase of the study in the BIO-91201 50 μM IVT group (P less then 0.05). No effect was seen with topical administration. Conclusion MARCKS inhibitor peptides were effective in reducing the severity of ocular inflammation and cellular influx in EIU.Damage evolution during fracture of metals is a critical factor in det
Mi piace
Commento
Condividi
